The survival of prominent families in Egyptian politics is rooted in a social structure that views the family as a framework ...
Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN Aspaveli (pegcetacoplan) is the first treatment of primary IC-MPGN and the first treatment for C3G and primary IC-MPGN ...
While Saudi-Iran rivalry remains a threat, Riyadh prefers an Iran that is constrained and deterred, rather than an Iran that ...
By Brad Sorensen, CFA NASDAQ:YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
Why do some tumours spread while others remain localised? The mechanisms governing the metastatic potential of tumour cells remain largely unknown — ...
New review reveals how non-genomic estrogen signaling undermines treatment response and fuels tumor progression Hormone receptor–positive breast ...
Aims The obesity paradox has been described in different cardiovascular conditions. Data on the association between obesity ...
Oasis urges Kobayashi Pharma shareholders to vote FOR a highly qualified, independent statutory auditor candidate*Oasis urges Kobayashi Pharma shareholders to vote FOR Oasis’s proposals to change the ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results from the positive Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating the ...
A viral TikTok conversation has reopened questions about why bacterial vaginosis so often returns, and what restoring the vaginal microbiome may have to do with it.